PURPOSE: The aim of this paper was to assess the concordance between results of DecisionDx-UM specific gene expression profiling (GEP) and fluorescence in situ hybridization (FISH) for chromosome 3 analysis, and between DecisionDx-UM GEP and multiplex ligation probe amplification (MLPA) in uveal melanoma undergoing intraoperative fine-needle aspiration biopsy (FNAB) for metastatic prognostication during brachytherapy. METHODS: We retrospectively reviewed consecutive patients diagnosed with posterior uveal melanoma who underwent intraoperative FNAB prior to placement of an iodine-125 radioactive plaque between 2012 and 2014. Two cohorts of patients were identified: Cohort 1 - tumors in which both GEP and FISH results were obtained, and Cohort 2 - tumors in which both GEP and MLPA results were obtained. RESULTS: Forty-four patients were identified for Cohort 1. FISH and GEP results were discordant in 7 tumors (15.9%). Forty-three patients were identified for Cohort 2. MLPA and GEP were discordant in 7 tumors (16.3%). CONCLUSIONS: Discordance between GEP and chromosome 3 status by FISH and MLPA occurred in our series at a rate of 15.9 and 16.3%, respectively. Caution must be advised when counseling a patient with a good-prognosis GEP "Class 1" result that the uveal tumor may actually harbor monosomy 3, which is associated with a poor prognosis for metastasis in nearly 20% of the patients.
PURPOSE: The aim of this paper was to assess the concordance between results of DecisionDx-UM specific gene expression profiling (GEP) and fluorescence in situ hybridization (FISH) for chromosome 3 analysis, and between DecisionDx-UM GEP and multiplex ligation probe amplification (MLPA) in uveal melanoma undergoing intraoperative fine-needle aspiration biopsy (FNAB) for metastatic prognostication during brachytherapy. METHODS: We retrospectively reviewed consecutive patients diagnosed with posterior uveal melanoma who underwent intraoperative FNAB prior to placement of an iodine-125 radioactive plaque between 2012 and 2014. Two cohorts of patients were identified: Cohort 1 - tumors in which both GEP and FISH results were obtained, and Cohort 2 - tumors in which both GEP and MLPA results were obtained. RESULTS: Forty-four patients were identified for Cohort 1. FISH and GEP results were discordant in 7 tumors (15.9%). Forty-three patients were identified for Cohort 2. MLPA and GEP were discordant in 7 tumors (16.3%). CONCLUSIONS: Discordance between GEP and chromosome 3 status by FISH and MLPA occurred in our series at a rate of 15.9 and 16.3%, respectively. Caution must be advised when counseling a patient with a good-prognosis GEP "Class 1" result that the uveal tumor may actually harbor monosomy 3, which is associated with a poor prognosis for metastasis in nearly 20% of the patients.
Authors: Justyna Dopierala; Bertil E Damato; Sarah L Lake; Azzam F G Taktak; Sarah E Coupland Journal: Invest Ophthalmol Vis Sci Date: 2010-05-19 Impact factor: 4.799
Authors: F Tschentscher; G Prescher; D E Horsman; V A White; H Rieder; G Anastassiou; H Schilling; N Bornfeld; K U Bartz-Schmidt; B Horsthemke; D R Lohmann; M Zeschnigk Journal: Cancer Res Date: 2001-04-15 Impact factor: 12.701
Authors: Michael I Seider; Paul J Stewart; Kavita K Mishra; Bertil E Damato Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2014-08-26 Impact factor: 1.300
Authors: Sarah E Coupland; Helen Kalirai; Vivian Ho; Sophie Thornton; Bertil E Damato; Heinrich Heimann Journal: Br J Ophthalmol Date: 2015-07-23 Impact factor: 4.638
Authors: Scott D Walter; Daniel L Chao; William Feuer; Joyce Schiffman; Devron H Char; J William Harbour Journal: JAMA Ophthalmol Date: 2016-07-01 Impact factor: 7.389
Authors: Tammy M Beran; Tara A McCannel; Annette L Stanton; Bradley R Straatsma; Barry L Burgess Journal: J Genet Couns Date: 2009-05-07 Impact factor: 2.537